Failed Start-Up - Would be lucky to survive the remainder of 2020
Pros
Pay, insurance, and most teams have some great people.
Cons
Oh boy, where to start. It is (or maybe "was") a start-up with a great mission. However, what's left after the first (and I repeat first but not last) grand exodus of employees is something short of a solid company with a product. Can you call a poorly developed app and a magical carbon market a product? The company has multiple COOs if that isn't a red flag; the North American COO has no experience and no right being a COO at this point in her career. Just because you have a MBA (which who doesn't at this point?) from Harvard does not make you special or talented. This probably explains why she reports to the, wait for it...., COO. Fun fact, there is also another COO for international who again reports into the "bigger" COO. The current senior leadership team has absolutely no idea what they are doing and this is just one of many failed start-ups under the current CEO, David Perry (Google it, and enjoy the reads). Side note, avoid anything with Flagship Pioneering, just as a precaution as Indigo was one of their blunders. The company also failed to establish a permanent CFO in 2019, which ultimately lead to the lack of budget considerations and likely ultimate doom of the company. Teams were hiring excessively for positions that were not needed but also just not applicable to the current business models. How many General Managers do you need for a single project? The best is when they hired people for roles, and yet the senior leadership and steering committee members didn't even know people were hired. Each Business Unit also tried to act independent from one another, so naturally each became isolated and closed off and roles were duplicated in each business unit. If I remember correctly, they had like 4 different Quality departments, and don't get me started on the size of Supply Chain. Essentially, after all the chaos and last minute ditch efforts to get financial backing, most of which are loans since investors are smart enough not to come near them, the company has fizzled into a tech company pushing their MarketPlace business model. Again, another attempt by the fearless leader who failed on this front before (read about Chemdex). If you're in Ag science, and looking at positions here remember they just axed 75% of R&D and will likely remove the microbial product in its entirety very soon. Which means with no physical product, why keep supply chain, marketing, product management, etc. If Glassdoor allowed "0" stars, I would give none, which is likely what most people think as well. So if you're considering a position here just think the current rating with 1.0 subtracted.
